<SEC-DOCUMENT>0001213900-26-051028.txt : 20260501
<SEC-HEADER>0001213900-26-051028.hdr.sgml : 20260501
<ACCEPTANCE-DATETIME>20260501171516
ACCESSION NUMBER:		0001213900-26-051028
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260428
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260501
DATE AS OF CHANGE:		20260501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Advanced Biomed Inc.
		CENTRAL INDEX KEY:			0001941029
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42548
		FILM NUMBER:		26933791

	BUSINESS ADDRESS:	
		STREET 1:		401 RYLAND ST
		STREET 2:		STE 200-A
		CITY:			RENO
		STATE:			NV
		ZIP:			89502
		BUSINESS PHONE:		86-21-20510823

	MAIL ADDRESS:	
		STREET 1:		401 RYLAND ST
		STREET 2:		STE 200-A
		CITY:			RENO
		STATE:			NV
		ZIP:			89502
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0288766-8k_advanced.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ADVB="http://advanbiomed.com/20260428">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_ADVB_advanbiomed.com_20260428 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20260428_20260428 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001941029 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000004" name="dei:EntityCentralIndexKey">0001941029</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-04-28" id="xdx2ixbrl0018" name="dei:EntityAddressCountry">TW</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="advb-20260428.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-04-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001941029</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-04-28</xbrli:startDate>
        <xbrli:endDate>2026-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_c20260428__20260428_zBB79OX3IZs1"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF<br/>
THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20260428__20260428_zcSd9SoH78sc"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">April 28, 2026</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20260428__20260428_zYGNHegEPIb"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000011" name="dei:EntityRegistrantName">Advanced Biomed Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Company as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 33%"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20260428__20260428_zrVdwtUcYfb6"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 33%"><b><span id="xdx_903_edei--EntityFileNumber_c20260428__20260428_zg3tkvgTW2Gj"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000013" name="dei:EntityFileNumber">001-42548</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20260428__20260428_zlfEpZFEwbL4"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000014" name="dei:EntityTaxIdentificationNumber">87-2177170</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or other jurisdiction</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(IRS Employer</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">of Incorporation)</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">Identification Number)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20260428__20260428_z4pcvO4XtyAe"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000015" name="dei:EntityAddressAddressLine1">No. 689-85 Xiaodong Road</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20260428__20260428_zXPNmF55fIol"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000016" name="dei:EntityAddressAddressLine2">Yongkang District</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20260428__20260428_zi2SE3qISnHg"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000017" name="dei:EntityAddressCityOrTown">Tainan City</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressCountry_dxL_c20260428__20260428_zhkTXAeS1OC6" title="::XDX::TW"><span style="-sec-ix-hidden: xdx2ixbrl0018">Taiwan</span></span>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--CityAreaCode_c20260428__20260428_zIWNlQ6blLp8"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000019" name="dei:CityAreaCode">886</ix:nonNumeric></span>-6-<span id="xdx_905_edei--LocalPhoneNumber_c20260428__20260428_zSRHdAsaf4Kk"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000020" name="dei:LocalPhoneNumber">3121716</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--WrittenCommunications_c20260428__20260428_zzGOqsFrA9A"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--SolicitingMaterial_c20260428__20260428_zeC1mhQqS1Wc"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--PreCommencementTenderOffer_c20260428__20260428_zkusUvo3R7A6"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20260428__20260428_zZZKGiP6itsl"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20260428__20260428_z2qLA4N1OJMa"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt:booleantrue" id="Fact000025" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--EntityExTransitionPeriod_c20260428__20260428_zH9uScPWFXl9"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><b>Trading Symbol(s)</b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20260428__20260428_zMQNrtsVOho3"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000027" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_909_edei--TradingSymbol_c20260428__20260428_ziTRXlo4e2Wf"><ix:nonNumeric contextRef="AsOf2026-04-28" id="Fact000028" name="dei:TradingSymbol">ADVB&#160;</ix:nonNumeric></span></td>
    <td colspan="2" style="text-align: center">The <span id="xdx_90D_edei--SecurityExchangeName_c20260428__20260428_z7mhq4EDXJwf"><ix:nonNumeric contextRef="AsOf2026-04-28" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"/><td style="width: 34%; text-align: center"/><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 2.01 Completion of Acquisition or Disposition of Assets.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As reported on the Current
Report on Form 8-K of Advanced Biomed Inc. (the &#8220;Company&#8221;) filed with the SEC on April 3, 2026, the Company entered into a
Share Purchase Agreement (the &#8220;Share Purchase Agreement&#8221;) on April 2, 2026, with Acellent Technologies (Hong Kong) Co. Limited
(the &#8220;Target&#8221;) and Mr. Xiaomin Chen, as the sole shareholder of the Target. Pursuant to the Share Purchase Agreement, the
Company agreed to acquire 100% of the equity interest in the Target in exchange for the issuance of 270,000 shares of the Company&#8217;s
common stock, par value $0.001 per share, valued at $4.00 per share, for an aggregate estimated consideration of $1,080,000. The shares
was issued in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended, and the transaction was completed on April 30, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 3.02 Unregistered Sales of Equity Securities. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information under Item
2.01 of this Current Report on Form 8-K related to the issuance of 270,000 shares of the Company&#8217;s common stock to Mr. Xiaomin Chen
is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has determined
to undertake a significant strategic pivot, transitioning its primary business focus from life sciences to artificial intelligence development
(the &#8220;Strategic Pivot&#8221;). In light of the Strategic Pivot, the Company and Mr. Yi Lu, the Company&#8217;s Chief Executive Officer,
director and Chairman of the Board, have mutually agreed that a leadership transition is necessary and in the best interests of the Company.
The separation of Mr. Lu from his position as Chief Executive Officer, director and Chairman of the Board is neither a resignation by
Mr. Lu nor a termination by the Company (whether for cause or without cause), but rather represents a mutual agreement between the Company
and Mr. Lu to effectuate a leadership transition in connection with the Strategic Pivot (the &#8220;Mutual Separation&#8221;). In connection
with the Mutual Separation, the Company entered into a termination agreement (the &#8220;Termination Agreement&#8221;), pursuant to which
the Company agreed to issue 39,999 shares of the Company&#8217;s common stock to Mr. Lu as severance compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the recommendation of
the Nominating and Corporate Governance Committee, the Board of Directors appointed Mr. Xiaomin Chen as Chief Executive Officer, director
and Chairman of the Board of the Company, effective as of April 28, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Xiaomin Chen, age 49,
has over 20 years of experience in artificial intelligence, large language models, and financial technology. He has been the Chief Executive
Officer of Acellent Technologies (Hong Kong) Co., Ltd. since 2019, where he leads the development of a financial-domain large language
model (FinLLM) and a trustworthy AI verification system (FinTruth) designed to meet the precision, explainability, and compliance demands
of regulated financial markets. From 2010 to 2019, Mr. Chen served as Chief Technology Officer of Shanghai Jianshi Network Technology
Co., Ltd., where he built and led a large-scale AI-powered image search platform. From October 2006 to August 2010, Mr. Chen was a Software
Engineer on the Core Search &amp; AI team at Google Inc., where he was awarded the Google Annual Outstanding Contribution Award (2009)
for his work in AI-powered web indexing and storage optimization at scale. Mr. Chen received a Doctor of Philosophy in Computer Science
from Rutgers University in 2006, and a Bachelor of Science in Computer Science from Shanghai Jiao Tong University in 1998.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no family relationships
between Mr. Chen and any director or executive officer of the Company. Except as otherwise described below, Mr. Chen does not have any
interest in any transactions with the Company requiring disclosure under Item 404(a) of Regulation S-K, and there are no arrangements
or understandings between Mr. Chen and any other person pursuant to which he was appointed as an officer or director of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As reported on the Company&#8217;s
Current Report on Form 8-K filed with the SEC on April 3, 2026 and under item 2.01 of this Current Report on Form 8-K, pursuant to the
Share Purchase Agreement, the Company acquired 100% of the equity interest in the Target and issued 270,000 shares of the Company&#8217;s
common stock to Mr. Xiaomin Chen. Mr. Chen is a party to the Share Purchase Agreement in his capacity as the sole shareholder and seller
of the Target, and accordingly has a direct material interest in the transaction required to be disclosed pursuant to Item 404(a) of Regulation
S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has entered into
an employment agreement (the &#8220;Employment Agreement&#8221;) with Xiaomin Chen, pursuant to which Mr. Chen shall receive compensation
at the rate of $12,000 per month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Termination Agreement and the Employment Agreement is qualified by reference to the full text of such documents, which are furnished
as Exhibit 10.1 and Exhibit 10.2 to this report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statement and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom"><b>Exhibit No.</b>&#160;&#160;</td>
    <td style="padding-bottom: 1.5pt; vertical-align: top">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom"><b>Description</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 10%">10.1</td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 89%; text-align: justify"><a href="ea028876601ex10-1.htm">Termination Agreement, dated April 28, 2026, by and between Advanced Biomed Inc. and Yi Lu</a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">10.2</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="ea028876601ex10-2.htm">Employment Agreement, dated April 28, 2026, by and between Advanced Biomed Inc. and Xiaomin Chen</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top">104</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">Cover Page Interactive Data File (embedded within the Inline XBRL document). </td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"/><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td colspan="2">&#160;</td>
    <td><b>Advanced Biomed Inc.</b></td></tr>
  <tr>
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr>
    <td>Date: May 1, 2026</td>
    <td>By:</td>
    <td style="border-bottom: black 1.5pt solid">/s/ Xiaomin Chen</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Xiaomin Chen</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Chief Executive Officer, director and<br/>
 Chairman of the Board</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"/><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2WWoVjPAxMYksQiJ6XXKMJd2R2c3qk/rLNiUaBoaZe89cIUJR0Fq3yHBeVSUcsetb5RAqbJDRXNA7ss02BT8rvGrrWBk3rj8wI8+gZxazRPn76By0xToFmcxlNI8XIOM0WsJhJ4KvnpFpdI3GadWCMjUcmHrW6BS/pg9H9SRD3WtMOiFbTSaFaCYn+Q2xjGLY06AexDcLZZmJIBwrEAXTvfeu/OnQfEnIW+x8nJ3ofwcfzCtKXQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea028876601ex10-1.htm
<DESCRIPTION>TERMINATION AGREEMENT, DATED APRIL 28, 2026, BY AND BETWEEN ADVANCED BIOMED INC. AND YI LU
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: right; text-indent: 0in">Exhibit 10.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: center; text-indent: 0in">TERMINATION AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">This Termination Agreement (this &ldquo;<B>Agreement</B>&rdquo;)
is entered into by and between Advanced Biomed Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and Mr. Yi Lu, the Chief
Science Officer, the Chief Executive Officer, director and Chairman of the Board of Directors of the Company (&ldquo;<B>Mr. Lu</B>&rdquo;),
and is effective as of April 28, 2026 (the &ldquo;<B>Effective Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><B>WHEREAS,</B> the Company has determined
to undertake a significant strategic pivot, transitioning its primary business focus from life sciences to artificial intelligence development
(the &ldquo;<B>Strategic Pivot</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: -0.05pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: -0.05pt"><B>WHEREAS,</B>
in light of the Strategic Pivot, the Company and Mr. Lu have mutually agreed that a leadership transition is necessary and in the best
interests of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><B>WHEREAS, </B>the separation of
Mr. Lu from his position as the Chief Science Officer, the Chief Executive Officer, director and Chairman of the Board of Directors is
neither a resignation by Mr. Lu nor a termination by the Company (whether for cause or without cause), but rather represents a mutual
agreement between the Company and Mr. Lu to effectuate a leadership transition in connection with the Strategic Pivot (the &ldquo;<B>Mutual
Separation</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">NOW, THEREFORE, in consideration of
the mutual covenants and promises contained in this Agreement, the Company and Mr. Lu agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.9pt; text-align: justify; text-indent: -9.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 1. Employment Agreement; Separation; Resignations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>1.1</B> <B>Employment Agreement Terminated and Superseded</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">The Company and Mr. Lu are parties
to that certain Employment Agreement, dated of November 1, 2022 and March 8, 2024, (the &ldquo;<B>Employment Agreement</B>&rdquo;). Effective
as of the Effective Date, the Employment Agreement is hereby terminated and shall be of no further force or effect, and the Company and
Mr. Lu are fully and finally released and discharged from any and all obligations, covenants, duties, and liabilities under the Employment
Agreement, in each case arising on or after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Notwithstanding the foregoing any
rights or obligations that, by their terms, accrued and became due prior to the Effective Date (including payment of any earned but unpaid
base salary through the Effective Date and reimbursement of properly documented business expenses incurred prior to the Effective Date
in accordance with Company policy) shall not be extinguished by this Section 1.1.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify; text-indent: -14.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 1.2 Separation from Employment; Mutual Separation</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Effective as of the Effective Date,
Mr. Lu&rsquo;s employment with the Company and service as the Chief Science Officer, the Chief Executive Officer, director and Chairman
of the Board of Directors shall end due to the Mutual Separation. The parties acknowledge and agree that the separation is pursuant to
this Agreement, is being implemented by mutual agreement in connection with the Strategic Pivot, and is not intended by the parties to
constitute (i) a resignation by Mr. Lu in any adversarial sense, or (ii) a termination by the Company for cause or without cause.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify; text-indent: -14.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 1.3 Resignation from Offices and Directorships</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Effective as of the Effective Date,
Mr. Lu hereby resigns from any and all officer positions and any other positions Mr. Lu holds with the Company (including any board or
committee positions, if applicable).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify; text-indent: -14.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 1.4 Transition Matters</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">From and after the Effective Date,
Mr. Lu shall have no authority to act on behalf of the Company (or to bind the Company) in any manner, except as may be expressly authorized
in writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2. Consideration; Severance Equity</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>2.1</B> <B>Severance Consideration</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Company shall issue to Mr. Lu (or
to such other recipient as may be required by applicable law, including for tax reporting purposes, consistent with the recital above)
39,999 shares of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<B>Shares</B>&rdquo;), as severance consideration
(the &ldquo;<B>Severance Consideration</B>&rdquo;).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify; text-indent: -14.9pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 2.2 Timing of Issuance</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Company shall issue the Shares
as soon as reasonably practicable following the Effective Date, and in any event no later than ten (10) business days thereafter, subject
to any required corporate approvals, tax withholding arrangements, and compliance with applicable securities laws.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.95pt; text-align: justify; text-indent: -14.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 2.3 Vesting; No Additional Service Requirement</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">The Shares shall be issued fully vested
upon issuance and shall not be subject to forfeiture based on continued employment or services; provided, however, that the Shares shall
be subject to the transfer restrictions and other restrictions set forth in this Agreement and as required by applicable law.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.95pt; text-align: justify; text-indent: -15pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 2.4 Securities Law Matters; Legends; Transfer and Lock-Up Restrictions</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Mr. Lu acknowledges and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">(a)&nbsp;The
Shares are being issued in a transaction that has not been registered under the Securities Act of 1933, as amended (the &ldquo;<B>Securities
Act</B>&rdquo;), and may bear one or more restrictive legends to reflect applicable restrictions on transfer under the Securities Act,
applicable state securities laws, and Company policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">(b)&nbsp;Mr.
Lu shall not sell, transfer, pledge, hypothecate, or otherwise dispose of any Shares except pursuant to an effective registration statement
under the Securities Act or an available exemption from registration, and in compliance with all applicable federal and state securities
laws, including, if applicable, Rule 144 under the Securities Act, and the Company&rsquo;s insider trading policy and any applicable trading
blackout periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">(c)&nbsp;As
a condition to issuance of the Shares, Mr. Lu shall execute any customary documentation reasonably requested by the Company to evidence
the issuance and applicable restrictions (including, if applicable, an investment representation letter or similar instrument), provided
that such documentation shall not be inconsistent with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">(d)&nbsp;If
the Company is party to any lock-up agreement, market standoff agreement, underwriter agreement, or similar arrangement applicable to
holders of the Company&rsquo;s equity securities, and such arrangement is applicable to Mr. Lu or to the Shares, Mr. Lu agrees that the
Shares shall be subject to such arrangement on the same basis as similarly situated holders, and Mr. Lu shall execute any customary joinder
or acknowledgement reasonably requested by the Company to effectuate such application, provided that such arrangement is not more restrictive
than the arrangements applicable to similarly situated holders.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.85pt; text-align: justify; text-indent: -9.9pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 3. Confidentiality; Non-Disparagement; Non-Disclosure of Agreement</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>3.1</B> <B>Continuing Confidentiality</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Mr. Lu reaffirms and agrees that Mr.
Lu shall continue to protect and maintain the confidentiality of all Confidential Information (as defined below) and shall not, directly
or indirectly, disclose any Confidential Information except as expressly permitted by this Agreement or as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">For purposes of this Agreement, &ldquo;<B>Confidential
Information</B>&rdquo; means any non-public information relating to the Company or any of its affiliates, businesses, operations, finances,
strategies (including the Strategic Pivot), products, technologies, research and development, customers, suppliers, partners, personnel,
trade secrets, know-how, processes, data, or other proprietary information, whether in written, oral, electronic, or any other form, that
Mr. Lu obtained or had access to during Mr. Lu&rsquo;s employment or service. Confidential Information does not include information that
becomes publicly available through no breach of this Agreement by Mr. Lu.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.2 Non-Disparagement</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Mr. Lu agrees not to make, publish,
or communicate to any person or entity any statement (whether oral, written, electronic, or otherwise) that disparages, denigrates, or
otherwise reflects adversely upon the Company or any of the Company Released Parties, including their respective products, services, practices,
or reputation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">The Company agrees that neither its
executive officers nor members of its Board of Directors will make, publish, or communicate to any person or entity any statement (whether
oral, written, electronic, or otherwise) that disparages, denigrates, or otherwise reflects adversely upon Mr. Lu; provided that nothing
in this sentence prohibits truthful statements required by law, SEC disclosure, or truthful testimony under oath.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.85pt; text-align: justify; text-indent: -14.9pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 3.3 Permitted Disclosures</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Mr. Lu acknowledges and agrees that
the Company may disclose this Agreement and its terms to the extent the Company determines, in its good faith judgment, that such disclosure
is required or advisable under applicable law or SEC rules or in connection with any filing with the U.S. Securities and Exchange Commission
(the &ldquo;<B>SEC</B>&rdquo;) (including a Current Report on Form 8-K) or related public disclosures.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.85pt; text-align: justify; text-indent: -9.9pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 4. Return of Company Property</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">No later than five (5) business days
following the Effective Date (or such earlier date as the Company may reasonably request), Mr. Lu shall return to the Company all Company
property in Mr. Lu&rsquo;s possession, custody, or control.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.9pt; text-align: justify; text-indent: -9.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 5. Cooperation</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Following the Effective Date, Mr.
Lu agrees to cooperate with the Company in connection with (a) any audit, review, or restatement of the Company&rsquo;s financial statements
for periods during which Mr. Lu served as an officer or director of the Company, (b) the preparation of SEC filings, press releases, investor
presentations, and other public disclosures relating to periods during which Mr. Lu served as an officer or director of the Company, (c)
any investigation, dispute, claim, litigation, arbitration, or administrative proceeding relating to matters about which Mr. Lu has knowledge
as a result of employment or service with the Company, and (d) reasonable transition matters relating to Mr. Lu&rsquo;s former duties,
in each case to the extent deemed reasonable by Mr. Lu.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.9pt; text-align: justify; text-indent: -9.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 6. Representations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>6.1</B> <B>By Mr. Lu</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Mr. Lu represents and warrants that:
(a) Mr. Lu has carefully read and fully understands all provisions of this Agreement; (b) Mr. Lu has been advised to consult with an attorney
of Mr. Lu&rsquo;s choosing, and has had a full opportunity to do so; (c) Mr. Lu is entering into this Agreement knowingly and voluntarily,
without duress or coercion;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify; text-indent: -14.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 6.2 By the Company</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">The Company represents and warrants
that: (a) the Company has the full power and authority to enter into this Agreement and to perform its obligations hereunder; (b) this
Agreement has been duly authorized by all necessary corporate action; and (c) the person signing this Agreement on behalf of the Company
is duly authorized to do so.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.9pt; text-align: justify; text-indent: -9.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 7. Governing Law; Venue</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">This Agreement shall be governed by
and construed in accordance with the laws of the State of Washington, without giving effect to conflicts of laws principles that would
result in the application of the laws of any other jurisdiction. Any action, suit, or proceeding arising out of or relating to this Agreement
shall be brought exclusively in the state or federal courts located in the King County, State of Washington, and each party irrevocably
submits to the personal jurisdiction of such courts and waives any objection to venue or inconvenient forum.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.9pt; text-align: justify; text-indent: -9.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 8. Severability</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">If any provision of this Agreement
is held to be invalid, illegal, or unenforceable, the remaining provisions shall remain in full force and effect to the maximum extent
permitted by law. To the extent permitted by law, any such invalid, illegal, or unenforceable provision shall be modified to the minimum
extent necessary to render it enforceable while preserving the parties&rsquo; intent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">9. Entire Agreement; Interpretation; Amendments</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">This Agreement constitutes the entire
agreement between the parties with respect to the subject matter hereof and supersedes any and all prior and contemporaneous agreements,
understandings, negotiations, or representations, whether written or oral, with respect to such subject matter, including the Employment
Agreement (as provided in Section 1.1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">This Agreement may be amended or modified
only by a written instrument executed by the Company and Mr. Lu. The headings in this Agreement are for convenience only and shall not
affect interpretation. This Agreement shall be construed as a whole and not in favor of or against any party by reason of authorship.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -14.85pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 10. Counterparts; Electronic Signatures</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">This Agreement may be executed in
counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Signatures
delivered by PDF, facsimile, or other electronic means (including via electronic signature platform) shall be effective as originals.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -14.85pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 11. Assignment</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Mr. Lu may not assign any rights or
delegate any obligations under this Agreement without the Company&rsquo;s prior written consent. The Company may assign this Agreement
to any successor to the Company by merger, consolidation, reorganization, or sale of substantially all of the Company&rsquo;s assets,
provided that such successor assumes the Company&rsquo;s obligations hereunder.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify; text-indent: -14.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 12. Notices</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Any notice required or permitted under
this Agreement shall be in writing and shall be deemed given when delivered personally, sent by nationally recognized overnight courier,
or sent by email (with confirmation of transmission), to the parties at their most recent contact information on file with the Company
(or to such other address or email address as a party may designate by notice in accordance with this Section 12).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: center"><I>[signature page follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">IN WITNESS WHEREOF, the parties have executed
this Agreement as of the dates set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">ADVANCED BIOMED
INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Mingze Yin</I></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mingze Yin</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer </FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Date:</TD>
    <TD>April 28, 2026</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YI LU</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:&nbsp; </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Yi Lu</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yi Lu</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 28, 2026</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea028876601ex10-2.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT, DATED APRIL 28, 2026, BY AND BETWEEN ADVANCED BIOMED INC. AND XIAOMIN CHEN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Employment Agreement (the &ldquo;Agreement&rdquo;)
is entered into as of April 28, 2026, by and between Advanced Biomed Inc., a Nevada State corporation (the &ldquo;Company&rdquo;) and
Xiaomin Chen an individual (the &ldquo;the Executive&rdquo;). Except with respect to the direct employment of the Executive by the Company,
the term &ldquo;Company&rdquo; as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the
Company and all of its subsidiaries and affiliated entities (collectively, the &ldquo;Group&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A. The Company desires to employ the Executive
as its director, Chief Executive Officer and Chairman of the Board of Director (the &ldquo;Board&rdquo;) to assure itself of the services
of the Executive during the term of Employment (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">B. The Executive desires to be employed by the
Company as its Chief Executive Officer and Chairman during the term of Employment and upon the terms and conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>1.
POSITION</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in; text-align: justify">The Executive hereby accepts a position
of director, Chief Executive Officer and Chairman of the Board (the &ldquo;Employment&rdquo;) of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>2.
DUTIES AND RESPONSIBILITIES</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">(a)</TD>
    <TD STYLE="text-align: justify">The Executive&rsquo;s duties at the Company will include all jobs assigned by the Board.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(b)</TD>
    <TD STYLE="text-align: justify">The Executive shall devote all of his working time, attention and skills to the performance of his duties at the Company and shall faithfully and diligently serve the Company in accordance with this Agreement. the Certificate of Incorporation and Bylaws of the Company. as amended and restated from time to time (the &quot;Charter Documents&quot;). and the guidelines. policies and procedures of the Company approved from time to time by the Board.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(c)</TD>
    <TD STYLE="text-align: justify">The Executive shall use his best efforts to perform his duties hereunder. The Executive shall not, without the prior written consent of the Board, become an employee of any entity other than the Company and any subsidiary or affiliate of the Company. and shall not be concerned or interested in any business or entity that engages in the same business in which the Company engages (any such business or entity, a &ldquo;Competitor&rdquo;), provided that nothing in this clause shall preclude the Executive from holding any shares or other securities of any Competitor that is listed on any securities exchange or recognized securities market anywhere if such shares or securities represent less than 5% of the competitors outstanding shares and securities. The Executive shall notify the Company in writing of his interest in such shares or securities in a timely manner and with such details and particulars as the Company may reasonably require.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>3.
NO BREACH OF CONTRACT</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in; text-align: justify">The Executive hereby represents to the
Company that: (i) the execution and delivery of this Agreement by the Executive and the performance by the Executive of the Executive's
duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any other agreement or policy to which the Executive
is a party or otherwise bound, except for agreements entered into by and between the Executive and any member of the Group pursuant to
applicable law, if any; (ii) that the Executive has no information (including, without limitation, confidential information and trade
secrets) relating to any other person or entity which would prevent, or be violated by, the Executive entering into this Agreement or
carrying out his duties hereunder; (iii) that the Executive is not bound by any confidentiality, trade secret or similar agreement (other
than this) with any other person or entity except for other member(s) of the Group, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>4.
COMPENSATION AND BENEFITS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">(a)</TD>
    <TD STYLE="text-align: justify"><U>Base Salary</U>. The Executive&rsquo;s base salary shall be USD12,000.00 per month (USD144,000.00 annually), paid by the Group in accordance with the Company&rsquo;s regular payroll practices, and such compensation is subject to annual review and adjustment by the Board.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(b)</TD>
    <TD STYLE="text-align: justify"><U>Bonus</U>. The Executive shall be eligible for Bonuses determined by the Board.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(c)</TD>
    <TD STYLE="text-align: justify"><U>Equity Incentives</U>. To the extent the Company adopts and maintains a share incentive plan, the Executive will be eligible to participate in such plan pursuant to the terms thereof as determined by the Board.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(d)</TD>
    <TD STYLE="text-align: justify"><U>Benefits</U>. The Executive is eligible for participation in any standard employee benefit plan of Company that currently exists or may be adopted by the Company in the future, including, but not limited to, any retirement plan, life insurance plan, health insurance plan and travel/holiday plan.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(e)</TD>
    <TD STYLE="text-align: justify"><U>Expenses</U>. The Executive shall be entitled to reimbursement by the Company for all reasonable ordinary and necessary travel and other expenses incurred by the Executive in the performance of his duties under this Agreement; provided that he properly accounts for such expenses in accordance with the Company's policies and procedures.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>5.</B>
TERMINATION OF THE AGREEMENT</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">(a)</TD>
    <TD STYLE="text-align: justify"><U>By the Company</U>.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i) <U>For Cause</U>. The Company may
terminate the Employment for cause, at any time, without notice or remuneration (unless notice or remuneration is specifically required
by applicable law, in which case notice or remuneration will be provided in accordance with applicable law), if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">(1)</TD>
    <TD STYLE="text-align: justify">the Executive is convicted or pleads guilty to a felony or to an act of fraud, misappropriation or embezzlement,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(2)</TD>
    <TD STYLE="text-align: justify">the Executive has been grossly negligent or acted dishonestly to the detriment of the Company,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(3)</TD>
    <TD STYLE="text-align: justify">the Executive has engaged in actions amounting to willful misconduct or failed to perform his duties hereunder and such failure continues after the Executive is afforded a reasonable opportunity to cure such failure; or</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(4)</TD>
    <TD STYLE="text-align: justify">the Executive violates Section 7 of this Agreement.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0 0pt 0in; text-align: justify">Upon termination for cause, the Executive
shall be entitled to the amount of base salary earned and not paid prior to termination. However, the Executive will not be entitled to
receive payment of any severance benefits or other amounts by reason of the termination, and the Executive's right to all other benefits
will terminate, except as required by any applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii) <U>For death and disability</U>.
The Company may also terminate the Employment, at any time, without notice or remuneration (unless notice or remuneration is specifically
required by applicable law, in which case notice or remuneration will be provided in accordance with applicable law), if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">the Executive has died, or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">the Executive has a disability which shall mean a physical or
mental impairment which, as reasonably determined by the Board, renders the Executive unable to perform the essential functions of his
employment with the Company, with or without reasonable accommodation, for more than 120 days in any 12-month period, unless a longer
period 1s required by applicable law, in which case that longer period would apply.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0 0pt 0in; text-align: justify">Upon termination for death or disability,
the Executive shall be entitled to the amount of base salary earned and not paid prior to termination. However, the Executive will not
be entitled to receive payment of any severance benefits or other amounts by reason of the termination, and the Executive's right to all
other benefits will terminate, except as required by any applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iii) <U>Without Cause</U>. The Company
may terminate the Employment without cause, at any time, upon a prior written notice. Upon termination without cause, the Company shall
provide the following severance payments and benefits to the Executive: (1) a lump sum cash payment equal to 12 months of the Executive's
base salary as of the date of such termination; (2) a lump sum cash payment equal to a pro rated amount of his target annual bonus for
the year immediately preceding the termination, if any; (3) payment of premiums for continued health benefits under the Company's health
plans for 12 months following the termination, if any; and (4) immediate vesting of 100% of the then-unvested portion of any outstanding
equity awards held by the Executive. Upon termination without, the Executive shall be entitled to the amount of base salary earned and
not paid prior to termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iv) <U>Change of Control Transaction</U>.
If the Company or its successor terminates the Employment upon a merger, consolidation, or transfer or sale of all or substantially all
of the assets of the Company with or to any other individual(s) or entity (the <U>&quot;Change of Control Transaction</U>&quot;), the
Executive shall be entitled to the following severance payments and benefits upon such termination: (I) a lump sum cash payment equal
to 12 months of the Executive's base salary at a rate equal to the greater of his annual salary in effect immediately prior to the termination,
or his then current annua1 salary as of the date of such termination; (2) a lump sum cash payment equal to a pro-rated amount of his/her
target annual bonus for the year immediately preceding the termination; and (3) immediate vesting of I 00% of the then-unvested portion
of any outstanding equity awards held by the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">(b)</TD>
    <TD STYLE="text-align: justify"><U>By the Executive</U>. The Executive may terminate the Employment at any time with a prior written notice to the Company, if (1) there is a material reduction in the Executive's authority, duties and responsibilities, or (2) there is a material reduction in the Executive's annual salary. Upon the Executive's termination of the Employment due to either of the above reasons, the Company shall provide compensation to the Executive equivalent to 12 months of the Executive's base salary that he is entitled to immediately prior to such termination. In addition, the Executive may resign prior to the expiration of the Agreement if such resignation is approved by the Board or an alternative arrangement with respect to the Employment is agreed to by the Board.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(c)</TD>
    <TD STYLE="text-align: justify"><U>Notice of Termination</U>. Any termination of the Executive's employment under this Agreement shall be communicated by written notice of termination from the terminating party to the other party.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>6.
CONFIDENTIALITY AND NON-DISCLOSURE</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">(a)</TD>
    <TD STYLE="text-align: justify"><U>Confidentiality and Non-disclosure</U>. The Executive hereby agrees at all times during the term of the Employment and after his termination, to hold in the strictest confidence, and not to use, except for the benefit of the Company, or to disclose to any person, corporation or other entity without prior written consent of the Company, any Confidential Information. The Executive understands that &quot;<U>Confidential Information</U>&quot; means any proprietary or confidential information of the Company, its affiliates, or their respective clients, customers or partners, including, without limitation, technical data, trade secrets, research and development information, product plans, services, customer lists and customers, supplier lists and suppliers, software developments, inventions, processes, formulas, technology, designs, hardware configuration infom1ation, personnel information, marketing, finances, information about the suppliers, joint ventures, franchisees, distributors and other persons with whom the Company does business, information regarding the skills and compensation of other employees of the Company or other business information disclosed to the Executive by or obtained by the Executive from the Company, its affiliates, or their respective clients, customers or partners, either directly or indirectly, in writing, orally or otherwise, if specifically indicated to be confidential or reasonably expected to be confidential. Notwithstanding the foregoing, Confidential Information shall not include information that is generally available and known to the public through no fault of the Executive.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(b)</TD>
    <TD STYLE="text-align: justify"><U>Company Property</U>. The Executive understands that all documents (including computer records, facsimile and e-mail) and materials created, received or transmitted in connection with his work or using the facilities of the Company are property of the Company and subject to inspection by the Company at any time. Upon termination of the Executive's employment with the Company (or at any other time when requested by the Company), the Executive will promptly deliver to the Company all documents and materials of any nature pertaining to his work with the Company and will provide written certification of his compliance with this Agreement. Under no circumstances will the Executive have, following his termination, in his possession any property of the Company, or any documents or materials or copies thereof containing any Confidential Information.</TD></TR>
</TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">(c)</TD>
    <TD STYLE="text-align: justify"><U>Former Employer Information</U>. The Executive agrees that he has not and will not, during the term of his employment, (i) improperly use or disclose any proprietary information or trade secrets of any former employer or other person or entity with which the Executive has an agreement or duty to keep in confidence information acquired by Executive, if any, or (ii) bring into the premises of the Company any document or confidential or proprietary information belonging to such former employer, person or entity unless consented to in writing by such former employer, person or entity. The Executive will indemnify the Company and hold it harmless from and against all claims, liabilities, damages and expenses, including reasonable attorneys' fees and costs of suit, arising out of or in connection with any violation of the foregoing.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(d)</TD>
    <TD STYLE="text-align: justify"><U>Third Party Information</U>. The Executive recognizes that the Company may have received, and in the future may receive, from third parties their confidential or proprietary information subject to a duty on the Company's part to maintain the confidentiality of such information and to use it only for certain limited purposes. The Executive agrees that the Executive owes the Company and such third parties, during the Executive's employment by the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person or firm and to use it in a manner consistent with, and for the limited purposes permitted by, the Company's agreement with such third party.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0 0pt 0in; text-align: justify">This Section 7 shall survive the termination
of this Agreement for any reason. In the event the Executive breaches this Section 7, the Company shall have right to seek remedies pem1issible
under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>7.
CONFLICTING EMPLOYMENT.</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Executive hereby agrees
that, during the term of his employment with the Company, he or she will not engage in any other employment, occupation, consulting or
other business activity related to the business in which the Company is now involved or becomes involved during the term of the Executive's
employment, nor will the Executive engage in any other activities that conflict with his obligations to the Company without the prior
written consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>8.
WITHHOLDING TAXES</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything else
herein to the contrary, the Company may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due or
payable under or pursuant to this Agreement such national, provincial, local or any other income, employment, or other taxes as may be
required to be withheld pursuant to any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>9.
ASSIGNMENT</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is personal
in its nature and neither of the parties hereto shall, without the consent of the other, assign or transfer this Agreement or any rights
or obligations hereunder; provided, however, that (i) the Company may assign or transfer this Agreement or any rights or obligations hereunder
to any member of the Group without such consent, and (ii) in the event of a Change of Control Transaction, this Agreement shall, subject
to the provisions hereof, be binding upon and inure to the benefit of such successor and such successor shall discharge and perform all
the promises, covenants, duties, and obligations of the Company hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>10.
SEVERABILITY</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any provision of this Agreement
or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of this Agreement which can
be given effect without the invalid provisions or applications and to this end the provisions of this Agreement are declared to be severable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>11.
ENTIRE AGREEMENT</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement constitutes
the entire agreement and understanding between the Executive and the Company regarding the terms of the Employment and supersedes all
prior or contemporaneous oral or written agreements concerning such subject matter, including any prior agreements between the Executive
and a member of the Group. The Executive acknowledges that he or she has not entered into this Agreement in reliance upon any representation,
warranty or undertaking which is not set forth in this Agreement. Any amendment to this Agreement must be in writing and signed by the
Executive and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>12.
GOVERNING LAW; JURISDICTION</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall be governed
by and construed in accordance with the laws of the Nevada State.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>13.
AMENDMENT</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement may not be
amended, modified or changed (in whole or in part), except by a formal, definitive written agreement expressly referring to this Agreement,
which agreement is executed by both of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>14.
WAIVER</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither the failure nor any
delay on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof,
nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or
of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence
be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence. No waiver shall be effective
unless it is in writing and is signed by the party asserted to have granted such waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>15.
NOTICES</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All notices, requests, demands
and other communications required or permitted under this Agreement shall be in writing and shall be deemed to have been duly given and
made if (i) delivered by hand, (ii) otherwise delivered against receipt therefor, or (iii) sent by a recognized courier with next-day
or second-day delivery to the last known address of the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>16.
COUNTERPARTS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement may be executed
in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all
of which together shall constitute one and the same instrument. This Agreement shall become binding when one or more counterparts hereof,
individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Photographic copies of such signed counterparts
may be used in lieu of the originals for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>17.
NO INTERPRETATION AGAINST DRAFTER</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each party recognizes that
this Agreement is a legally binding contract and acknowledges that it, he or she has had the opportunity to consult with legal counsel
of choice. In any construction of the terms of this Agreement, the same shall not be construed against either party on the basis of that
party being the drafter of such terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[remainder of this page left intentionally blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, this Agreement has been executed
as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">/s/ Mingze Yin </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">Mingze Yin</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>Executive</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Xiaomin Chen</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">Xiaomin Chen</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>advb-20260428.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 86o5s7xRiXhun8uDb31cWa6FeaPty5BxqZkxsmx2HZk6vyQg83vJfCdxyda2sVsH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ADVB="http://advanbiomed.com/20260428" elementFormDefault="qualified" targetNamespace="http://advanbiomed.com/20260428">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://advanbiomed.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="advb-20260428_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="advb-20260428_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>advb-20260428_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>advb-20260428_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="advb-20260428.xsd#Cover" roleURI="http://advanbiomed.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://advanbiomed.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 28, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 28,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Advanced Biomed Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001941029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-2177170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">No. 689-85 Xiaodong Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Yongkang District<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tainan City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">TW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3121716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADVB&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0288766-8k_advanced.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://advanbiomed.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>advb-20260428.xsd</File>
    <File>advb-20260428_lab.xml</File>
    <File>advb-20260428_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0288766-8k_advanced.htm">ea0288766-8k_advanced.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0288766-8k_advanced.htm": {
   "nsprefix": "ADVB",
   "nsuri": "http://advanbiomed.com/20260428",
   "dts": {
    "schema": {
     "local": [
      "advb-20260428.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "advb-20260428_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "advb-20260428_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0288766-8k_advanced.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://advanbiomed.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-04-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0288766-8k_advanced.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-04-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0288766-8k_advanced.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://advanbiomed.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001213900-26-051028-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-051028-xbrl.zip
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MF1)7;$#F%!-Z>1 L *9T!DH9DCI4"KWTO+I+0'/Y$"/8'%WFE@"[R38%;4U
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M?U$$: [-#^HW"H$QE*3IJGWBZ]YLL-]2F[]C?]EO8C5;_@=02P,$%     @
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M[SDS$$$ < AK ^,<'1@-#GP_^YF3TW$J5LWJ \[ D 6=QM[FIQ*&)U822'U
M.1B#H/'PR*8.6/T!A1G#L3NFICEWL0-P7!0B?7SYAACP4?A\ )368L 3@9Q#
MR)ZG[2JOJ]SOHDW()*3[0OT(G!LNZW2LN(VF*(@\Z>HUD<?7I CD\I"3@B%!
MF5 XN[.$A]-" $1)D?\LPO8M_YA4'H-0/"^!?V (98]=]<5V"N3&); >' =!
M):"2>D@]?BIN2DWN,G?"F!5&D?!W%L@!Z6*]'JQKC/' 2L9C;YYE>69C'F!&
MQ2<2)IXI0MH!WR-2.(>6"* MS5@7JT8X2&,#U4YHQ%*4FHK4^66-,Q$1_B#B
MD]$.*913Y7)Y Z\#/,:[PZ"ICG1ANF]$@:S7.3!>:]"^ER&]&GDI#^B0;*@P
M?&64;#]7[^U!ZRBURW?,Y)T-C+,DY^1M.M=E+!72N(BWH\J#L>7\X$F*G5BM
MV-$-3WDZ@U"HE(;H.P[^1?L:DXA!GE,LIQ+H+G'S@",$WQTA^<2F>,8KG1=,
M6.'74L3$U E^6OTQ@AO:!C.%RA/FQ[ZNGT?.,N0]D^ZY&UBZZ%XGO+U6=8<G
MY*$I<NH:&7#J2*F6RY=3V+T"T17 1A.IDLV0_T7(=$Y<V@ FPPJC"TG(A9"M
M$VZ=GIZI3!8LF0,,GD (/("HJHGOC)W?7!0S@2$>SN@X8W>P#3C1JRC3-&20
M7R(AX !TV:>?0@Z;>'^JRTW(+A3/9!ZE$C6#P>8; L\R(2<9JS![SM.A+$5#
M)G*"KA$6GD,\B@&XU5*7!',>,,/T52I@Y(R$^-S&E!>4B7P S.!00/9PE7>A
MX8F TR'V=L?<="796,R@BH5IH4/:!.Q)C^R)<@-#E P!@J4/""S9Q83#H_L"
MM+DK)2^WB_37QGU@L5Q.:!F885+2MGON!(QZHF&! C"DW7>6#F:O$O[O=#C:
MQ\UQ&1UB:OW.MOM #U9D0J1+B !,MC4,F#^J9EGHV"[&KFQ/0".'[R1U.#AQ
MZ9QP"MD":LO;"?3Z&))(5H$$A98\85ULO6!3WTR"HW&0"_8(TGC^M^<,(?Y$
M9F7F*P7I8%QN&3FV90@#^W,YX*8M[-$ *Q?2LHW!IY*VBCL3,C9JC=T^1 .0
MP'+Y*F-9Y9!L37G">T3U >B VG$]T.Q%<"K4"HN$33JH<5'(^7*Y]"\RGATI
M.%B LFRBVDQ4ZHO-A1""B80?O05;*;D.\4D0C,*?Q9M^SF($C"TN#&A#BXPA
MXX0+M 1"!Q$$J9 7C4**8=BP6&S7D1$Z!HSATA9B#Q5JQ#P<]&,G!PMB#@JI
MP84.0H9IZ;P*0(JYHM=^TU(F",6VG?X8%(+F3*&A+#,!2Y50?"T29"5[U"5_
M\#4"VXH6([U 5X-X@<H>Q(!]3HB_45;^>X0SKER]4)1<4\%Y0BE:;I82"QZ<
M$3Q>'(I&[K)Q<UT-=Q[1J\JM\8S2K4PQ5;'S^57:N+)3R"9CURO6<0'[(Z5H
M)$JVF5(\=G-G*TO=TB5@<./XK4IJ'9ZMUG7;0;4Q52F#>C(^OZFRR(5P.5;I
MM H[NLQ7[(5VJ97:G0#M_A>ISF+5*)RZ)F1C);ZC0^YM?.K:F ]8/E^12A6-
MN9<MW#Q8&U#3]". 2/:9H"IX=+PWH?V:UZ2(XX&!?.G;OVS'\,BV;TNW)5WC
M2#+)UZ2X8D)P<!&W7ZCA]Q#WJ5>&A0O+OL+WQJ8IJ4'NBS'LFN&]04^DO&U$
MB] ;.Q87 V8D*':F#WB7N\",3%ZB#WVA*<#<-]RONG]O>)PZ+W67T46<!-F*
M?*=/L!$>)UZT\OR/:=!\K ]S@Z; 52V;P&Q?J,YMR4RUW#5=:]Y"YQT-B&<9
M@[RZ]$V-C&MH/IXK[;H6Q>5N1*??A=RKF-(*I92VL[.]W)88VY@2[,]OR2IJ
M8^R*ULY<_Z*P=5-+Y=]6:0HEZM7SC.:T4FEO=S>79]-\+IW/#%Q@5*P=2Q%#
MU@&B5:P4&BU4+#_*CNU'P 'RA. @2Y_!]&OL+WX2IR5WM:>RZ/DL?1X;-<7&
M.(/_K5P,N_3G,7,C"4:^%E^+K=@4B[4_V9O4Q/"'JG+I,76I>AG:%AM"\FEX
M68(7<C;E[\TA^(MS F>XC>?B;]$7N;;93MLG%]*XB H"][H=]LE?V&[Q7R_>
MQKUXU>BO8%'LWB?XKNT*J3FTRW7_M[+@EIS;R.A\I '.GR4[3Z6D_-?=M[)E
MX"U>./9V[_]O-]^=USI7K3=X^?]W2$W49>[%EC4O%?=J8DM=5G%W5Z/M5NY"
M>FJ,S9DZ6#;"Z8.7ZGO'#;9ZYW&703[9\\^L53E.#DA@V6Z,9[,2'!V[ ]L!
MVV*\<A;R ]V5BKT&$?MV3)#L^'=B+\>UJ^X1[>;6AY?>L)TGC2HL#(O#+]^P
M7B%G=$;R_JO>PVLZFE4V"OJ3U:S(+@1'JTAXXIM&JR\+[4D=(^HW&,0?+W^W
M%P"LC7@*H8CGE KWOPCG#2,<[2TCG!_E-D$$W%-^<U_IZ%;>,Y>OL)O_PC_V
M87KRU6A\[-_5/K6ZV5IO^E6[OK;_^GI9FYY]OA.?^(?=FYN/9Q\,K:7IA?N[
MK'-ZSJ\H*.L75BKKS:L/K=S)?6'V_HC]U;[2!7.[.ZW:???#<>OFO+8G1$X[
MZI2<AW>.<WUT5W"^EB;-TI_]+U/Z=^O2VML]FN6F'?MDJ$_-\V;IIGEQEKL6
M'P8?BA\?K-')R&@6WE'CNG[V]4H?OG>N=X_:V5&__+[<;AT7KMVS"W[2[;3I
M":U_MO[\I$V_OCO]G-NML>FQ?OKER_!#\VCB-&HWG8<>&V<OK$^]AM6\_G-:
MLCX4[-Y$[_U==S_>?#H\5!S)XN\IE+\"TQV:U?\'4$L#!!0    ( .:)H5QB
MZ'3XLQ@  &B&   5    96$P,C@X-S8V,#%E>#$P+3$N:'1M[5U;<]NVMG[7
MC/X#MN>T8\_(BB])VEC>GO%%:3W;<3RV=CN9,^>!(B$)#46P!"E'_?5G70 2
MI"3;;7V+TSPXDB@"X,*Z?.L&[?\\^'!VT&[M_]P_/('_!?[;'YP.SOH'^Z_X
M?[CZRE[>/_IX\DE<#3Z=]?^]-M))OB>VM])<#-14&G$NK\6EG@9)AS_HB"N9
MJ=$:W BW7M3O&^HXNL/-/3$-LK%*]@1^=8O_=K?3O"=R^27?#&(UAHN9&D_<
M1RJ)),ZPI9*U@_Z7B1JJ'&;J;N^_NGB$I80PN<R6K>7[9&C2WE.O8M"__'!Z
M?C@X_7@N#G^Z[/<_],\'JQ;U%]?37,UOA<G5:'X;">Y[ML%$&3&0V50E0:YT
M(@['F913H(58S_':]W'T>Z%[^T<'Y97]5T<'WV?T\4:[!=\A0LI(J"378C@7
M01*)H<ROI83QHEF0A'#Q2.DI_'>:A-V."&#ULR *1*BS5&<\-4PHO?F.]30-
MDKD_6X>&_I!UQ2<ESHJ.P#N.)TJ.VJVK4$F82'P<C50H,^^:Z'^189&KF7<Q
M4ID,<YW1@,>30&5 2*%'=->1#K((WYS8;QEWQ:Y)K%?+Q-6<%;55MELX*A)F
M-(+[<>* ACA,,Q6+G1\[8F=KYVWS@?OEMT^"7/HC=A^+'6 5CO^.#AYQTE]_
M[E_V#Z\Z.&V-T!,@7"1S8E 9M5O 8 6(:I8'GX&HPL!("K8T 'XU.?"1'*M0
MI&JF<V" +$B,0M92R5BHW @@/RQL+H:%@>&,$2,=%O WTU,1JY$4AIG(")@G
MR'(<6@4Q,K:,8=7$8)&<R5BG* GM5F,+K\HU7. :_#U\))%NZ+/-K>[6FS1_
MDIV]82G^?H,*28#Z8)V<E#6HV*EQA-, 9P4P!\C*M,B+(([A NJG"+X;Y, 9
ML0R 3<Q$I1X?H$PF$O;7(!>0D"8T^%":'->!>LSD37%_-&W\U.(G<%Y\<"/3
MP&IE#;K5TIOD!(U"JBT]03HK-?NP&EB9=BN1"J["+0*V"9Z"5P@6QRXPP>%$
M[IDSN%;3V]<322.,X)MA4!@IX,4UC*J+G#\ (S.$U_#T^+U,IC 5\*^!@9G5
M0+N7-M)9N14,"EJ$34 !_+R:*1,P@TF"NA_>X6*624'36GRPB[DJM^H)M,UC
MPY7SC[_"[<BM[S]>]CN6=$8!52MN13KQ5L'%F4P"VCW8E13X5QE8"]R3!VA0
M6/Z!HTMPLU+9T*8CPX]T'.MKL_< *'7GA^Z[.RK3=]UWI$SO%3%OYCK=8_+;
M#X8ZS_64/EL[$-M=T9^FL9X3\Y<TZXF*"7OBLA)-X]9U+[Q1ITLL1_=OUFXC
M $RWC5[2$;U<1HL23 -S(?=<%2E(O(QDY*_PY4GF8(749%*DB*2D(?!&UCE$
M_ :2MXQ^8!B(=J#[ST%XIT-0PMN$EW=XW" +)X(1].O. H1>,F(-2(L29(,:
M+^U\'7FS"EBZN: IP"I(M"KU;383P"!@#G#$1(M1D3DS$Y*)83/ _DM#P93F
M%6DU*@C*P+=&,#J^SB18#6.GB90))[ K\):,L:,V3JZ'L"4L=IU*\0$]"Z0^
M3QVK8*ABA1\PCFX\:KOE;03LD R V"%,#XM3!F$TZE@PLJ/<W5LCW:,Y*H]L
M=G2.9MGD0$,D CXX;*T<:WP'F]!N47C%(&V\?2!V[U@0HC)B&MR),,P*NZ-#
M&093<"H*B=X)W$Y"TJ2K6%=)&!<T>1HP5P*GX?;+($-#AIBE2-)  3\-<<-,
M$"/(S2>9+L:396/B])E4TV$!"LH-"382%!;P702N$7Y(8UMW27Y)98(&%%93
M9.CRW[!FPO7PJ#J+, + P,;Q?:IC%<XWK-PD&J$4#)_# Q;*3'#2.5OF*XN+
M0.^NY*Z_87)W=^YL<K=?/XW-W?',*XM]); ]P3A0^##PI=J8?B.<LD1U.V7Z
M?690X0/+5FJ\1-:^G3(RFX%#<N^>3+NUVI5AII>HST'LK? L[&-7H$VUQA,$
MZ7.BKV,9C5EP&8Z2.6TX;.B?@407&!/)-<+A.KZ%=T-)$1$@C70B/G>0N7)N
M[N:7L&%!QUKG%"@!<8F<W^56C^M H)ZKO"!MMK'2AT.E@7L3S0 W@=6!)1E4
M.AW4K>N*[KS!PUOMV'VCVF/7!^2L/IASV2<JN1*<TON%ZU^KZG (C]G3+ %:
M+/AE%(0)B=_0!/JJS]V L*=F4?UX-AW?#EE19"@ITZG*<Y#O<B@06S#W:0I6
M,QC&<G5$^&4S\VLQJ.(F'P*@4?:"F?8]<UZT$FY7/,LFA0*BX'X$!>B]3.5S
MBF.'.:+VH82OC!82&8S>AJKNEVPX-0Q/D*"-DU]""6L%X9D&<\9J&!@SZ*SP
M9']@>![NNH9YD:7K>OF)' .8[U^;F^*]DG&T)RZ"L<18Q>\%6G>86VQNVHSN
M_LGI+VYA/C-N[RSAQK?XV1!PK<S*SXYBL-# H2 5P@"XC=8.]@>'1V=]<=P_
M.[LX/#DY/?_IWVM;:_3^ZN+PV+VWL]KQ0AW'06I@=>Y5#S1'E$^05%O?]022
M;=, N9EV.,VE&P-,9@X*(G94@4=8&C09G+@[[-"[N]^M83;[9-FUU]\M2YRN
M_OYNX_OD&E4[@S>]&ESB'Z0/_ ^T7[(-PTP&GS>'$AVM/4 2N'?^UKQ=LC.X
M7;"PB_I66OU1L49M2H]!7B&',%,\M#)[3,6YTP4Q]**D* / *N25]7\O0$\\
M?)SNOL3_>00!=ZH@8$7*&HT?*-K7W7FCDL<P3G<(\['-4<:P$V,MT3HB&'AK
MBG!B 1$@3)4J="DJ^Y&!%E89>PH5KA%Q<(V!)X>+$,WGP1=,P^B,S JX-@"*
M)(6X@-PFKWEV.%..3LQ0S^1&N[7[KO/NW3M<*1BKANTK742$6V @3:[#SQUT
M6<0LB.&9_F>KN[6U+5)X AJ@&6R\HE$;]0G@W94,44M-+.:*5S/.K7G_QT-Y
MCP[R=KH[>!_%&D?BU* C&\IO2930QR;6HA"UT9QG!6MH= )",A=I!IC."@QG
MHUQ0LAG(MBENBA/.4%( ',8!@\D@@74E8GU[:Z.*\$7!G (A,!MBS@Z(\? W
M&))$&H<IY=95[D@4WTR#R,##HZRB,*+'0WY-!AP^IG""C4"#L(&P5P%!3_:-
M#(N,8].@!LQ#,?^;9^WC[(##_HLTJ.MZXER+PR@B;X="0QRJNN0MX-S&2_5]
M!J445+D5DH_(YDAF0"1T.8J48EZL)KQ<C(TI6_Y% P7&9"157H F'U)&15.
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MG-E)Y;=H6'_HBI_T3&9$Q+/@NB=^D4GQ$!U4ST9L:HQ2EG2-B0K$AWPB+YU
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M=>,F]^X&>[=;L/<))QJU ["X&?Y:N'MZ!=SUQ>?PCBBV 7CB.GCW<]G:OM_
MFQM'E3<VLBU\;Z5\%@ADUA+;*H^Y\^>-*L"?44PJ. T<C2 S/-B:T@_0M6B#
M5IL8(4M@HSFE\;F:'%SD E#):-+G->XH%L/;_Y+V0T1Q;+SQ3,C6'8Q5*Q*7
M-%NE"<\=!QAEL)*LD)L6X=,9M^O9&4W1DH[B!7 =#M:^-IBZ@$4N'^IQOQ4E
MF_BV(_K $6.N/->47CA='4O@U&%6?9KKO+9 58JGR_GG][S3P!<+"2U\%$@
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M^Q*V4*F#Y((S/ D*JE2%K9AT976(YE!1 ?3EE5C,@M]U[K@P#C%*-&J-L$)
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M,L[NVUQC;-9JFZYL;;71%:>IBGI7"WIOWJ%[#*^G6RRK)$^V%9DRO]#VPHM
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M7,BQ%B;9N""5)+KZ;5(-E"?J[=AK^&KQ^4L72["LB8*AH<COD,L$5TNX*@/
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MD\/3XP]4<NC-\.W)J_\'4$L! A0#%     @ YHFA7!XLYRHL P  ZPL  !$
M             ( !     &%D=F(M,C R-C T,C@N>'-D4$L! A0#%     @
MYHFA7&'2=_S]"@  ?X8  !4              ( !6P,  &%D=F(M,C R-C T
M,CA?;&%B+GAM;%!+ 0(4 Q0    ( .:)H5Q;Z-+$7@<  -I7   5
M      "  8L.  !A9'9B+3(P,C8P-#(X7W!R92YX;6Q02P$"% ,4    " #F
MB:%<%%%!7[H8  "Y=@  &0              @ $<%@  96$P,C@X-S8V+3AK
M7V%D=F%N8V5D+FAT;5!+ 0(4 Q0    ( .:)H5QBZ'3XLQ@  &B&   5
M          "  0TO  !E83 R.#@W-C8P,65X,3 M,2YH=&U02P$"% ,4
M" #FB:%<PX/UJY$>  #HL   %0              @ 'S1P  96$P,C@X-S8V
B,#%E>#$P+3(N:'1M4$L%!@     &  8 D@$  +=F      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ea0288766-8k_advanced_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="advb-20260428.xsd" xlink:type="simple"/>
    <context id="AsOf2026-04-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001941029</identifier>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-04-28" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-04-28" id="Fact000004">0001941029</dei:EntityCentralIndexKey>
    <dei:EntityAddressCountry contextRef="AsOf2026-04-28" id="xdx2ixbrl0018">TW</dei:EntityAddressCountry>
    <dei:DocumentType contextRef="AsOf2026-04-28" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-04-28" id="Fact000010">2026-04-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-04-28" id="Fact000011">Advanced Biomed Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-04-28" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-04-28" id="Fact000013">001-42548</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-04-28" id="Fact000014">87-2177170</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-04-28" id="Fact000015">No. 689-85 Xiaodong Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-04-28" id="Fact000016">Yongkang District</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-04-28" id="Fact000017">Tainan City</dei:EntityAddressCityOrTown>
    <dei:CityAreaCode contextRef="AsOf2026-04-28" id="Fact000019">886</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-04-28" id="Fact000020">3121716</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-04-28" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-04-28" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-04-28" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-04-28" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-04-28" id="Fact000025">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2026-04-28" id="Fact000026">false</dei:EntityExTransitionPeriod>
    <dei:Security12bTitle contextRef="AsOf2026-04-28" id="Fact000027">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-04-28" id="Fact000028">ADVB&#160;</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-04-28" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
